- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Mi | Creo Medical - FY25 results validate growth strategy | 147 | Creo Medical has reported its headline FY25 results, delivering fully on its guided revenue and cost savings targets for the year. Core revenues were reported at £6.0m, 50% y-o-y growth and within the... ► Artikel lesen | ||
| Di | Team Internet Group - DIS and Comparison support year-end trading | 119 | Team Internet's trading momentum improved in Q425, supported by accelerated performance in Comparison and Domains, Identity and Software (DIS) and cost control across all segments, despite ongoing market... ► Artikel lesen | ||
| Di | 4imprint Group - A good end to FY25 | 153 | 4imprint has delivered a better-than expected profit for FY25, which is testimony to the strength of its marketing and operations in what has been a challenging and uncertain market after the tariffs... ► Artikel lesen | ||
| Mo | Baker Steel Resources Trust - A 50% return in 2025 with good portfolio breadth | 159 | Baker Steel Resources Trust (BSRT) reported a strong 17.7% NAV total return (TR) in December 2025 as a result of its customary year-end review of unlisted carrying values (with the Bilboes Gold royalty... ► Artikel lesen | ||
| Mo | Noctiluca - European OLED challenger | 170 | Noctiluca is a dynamic advanced materials company specialising in OLED materials for displays and other photonics applications. It has a growing base of engagements with key players globally and is... ► Artikel lesen | ||
| Fr | Greggs - Weak consumer outlook prompts more caution | 264 | Greggs' Q425 trading update showed continuing weaker trading against easier comparatives from Q424 than it had faced through the first nine months of 2025. Management has given a very clear message... ► Artikel lesen | ||
| 15.01. | Foxtons Group - FY25 results to be in line; M&A opportunities | 1.293 | Foxtons Group is expected to achieve its FY25 profit expectation despite external factors affecting demand. However, these factors, plus an internal decision to maintain headcount to capture growth... ► Artikel lesen | ||
| 14.01. | Frontier Developments - Guidance raised following H126 results | 311 | As the industry recovers from its post-COVID-19 hiatus, player engagement is the gold standard for sustainable value creation for developers. We are encouraged not only by Frontier's creative management... ► Artikel lesen | ||
| 14.01. | Picton Property Income - Strategic review and formal sale process | 198 | Picton Property Income (PCTN) has announced a comprehensive strategic review to consider a range of options to maximise value for shareholders, under the framework of a sale process. This proactive... ► Artikel lesen | ||
| 14.01. | Primary Health Properties - Merger synergy underpins increased DPS | 265 | Primary Health Properties (PHP) ended a transformational year with strong momentum in both organic rental income and the integration of Assura into the enlarged group. In the two months since the Competition... ► Artikel lesen | ||
| 13.01. | Nanoco Group - Seeking IP damages from Shoei | 226 | Nanoco's announcement that it has filed a counterclaim and answer to the filing of a declaratory judgement action from Shoei signals that it will pursue the monetisation of its IP with Shoei, or its... ► Artikel lesen | ||
| 12.01. | Cereno Scientific - Entering a value inflection phase | 277 | We refresh our investment case for Cereno Scientific as the company enters a key value inflection period, with its lead asset CS1 expected to initiate a Phase IIb study in Q226, followed by Phase II... ► Artikel lesen | ||
| 12.01. | Phoenix Spree Deutschland - FY25 condominium sales beat expectations | 291 | Phoenix Spree Deutschland's (PSD's) FY25 condominium sales of €36.0m reached a new high level and were substantially ahead of the €30m target set by the company. Momentum remains strong, with December... ► Artikel lesen | ||
| 12.01. | Corero Network Security - Ending 2025 with exceptional orders | 178 | Corero Network Security had an excellent end to 2025, with an exceptional level of order intake in the final quarter. After the challenges seen earlier in the year, the progression of order intake over... ► Artikel lesen | ||
| 09.01. | Immix Biopharma - NXC-201's path to BLA submission | 313 | Immix Biopharma recently reported a positive clinical update for the registrational NEXICART-2 trial, evaluating lead CAR-T candidate NXC-201 in relapsed/refractory amyloid light chain amyloidosis (r/r... ► Artikel lesen | ||
| 09.01. | OSE Immunotherapeutics - Renewed focus on advancing core assets | 310 | We revisit our investment case for OSE Immunotherapeutics following the recently presented strategic plans for 2026-28, reflecting a more streamlined focus on advancing its core clinical assets, Tedopi... ► Artikel lesen | ||
| 09.01. | BioVersys - Targeting resistant and threatening indications | 329 | BioVersys (BIOV) is a Swiss clinical-stage biopharmaceutical company developing novel anti-infectives to address antimicrobial resistance (AMR). Lead asset BV100 targets carbapenem-resistant Acinetobacter... ► Artikel lesen | ||
| 09.01. | International Public Partnerships - Operational and strategic progress | 260 | International Public Partnerships' (INPP's) recent portfolio update, for the period 1 July 2025 to 12 December 2025, showed the portfolio continuing to perform well and in line with expectations. Capital... ► Artikel lesen | ||
| 08.01. | Faraday Future Intelligent Electric - Announcement of five-year business plan | 329 | On 7 January 2026, Faraday Future Intelligent Electric (FFAI) held its first-ever stockholders' day, with the company announcing its five-year business plan alongside a three-stage delivery roadmap... ► Artikel lesen | ||
| 08.01. | Herantis Pharma - Biomarker data bolster HER-096 potential | 271 | Herantis Pharma has reported encouraging results from the biomarker component of its Phase Ib trial testing HER-096 in patients with Parkinson's disease (PD). The key takeaway was that the data showed... ► Artikel lesen | ||
| 08.01. | P2 Gold - Bonum pretium | 221 | P2 Gold owns 100% of the Gabbs property in Nevada, where past exploration has identified a resource of 2.0Moz Au and 3.5Moz AuE in an area with paved highway access and power lines crossing the property... ► Artikel lesen | ||
| 08.01. | JPMorgan European Discovery Trust - Opportune time for European small-cap stocks | 297 | JPMorgan European Discovery Trust (JEDT) is benefiting from improved performance under the management of Jon Ingram, Jack Featherby and Jules Bloch, who took over the reins at the beginning of March... ► Artikel lesen | ||
| 07.01. | Hansa House View - Q425 | 205 | At the start of the year the market was buoyant on the hope that a Trump presidency would lead to more market friendly policies that would turbocharge the economy. However, Trump 2.0 appeared to be... ► Artikel lesen | ||
| 07.01. | Topps Tiles - Encouraging pick up in revenue growth | 211 | Topps Tiles' Q126 trading update, to 27 December 2025, shows an encouraging pick up in revenue growth towards the end of the period despite being up against a tougher comparative, with continued market... ► Artikel lesen | ||
| 05.01. | Regional REIT - An active end to FY25 | 232 | Recent announcements from Regional REIT (RGL) include further progress on asset disposals, with the total for 2025 ending a little above the £40-50m range targeted by management; a successful refinancing... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .